Womb WatchAI

Founders, Backgrounds, and Bench

Womb WatchAI is a solo-founder venture led by Quanda Francis, who serves as Founder and Chief Technology Officer [WOMEN OF WEARABLES, retrieved 2024].

Company Overview

Womb WatchAI was founded in 2024 by Quanda Francis, a serial tech entrepreneur. The company is headquartered in Brooklyn, New York, and positions itself as a biotechnology firm building an AI operating system specifically for women's health [Womb WatchAI, retrieved 2024]. Key early milestones include the development of a proprietary AI framework, the Bio-Intent Orchestration System™ (BIOS™), and the filing of six provisional patents [Instagram, retrieved 2024]. The company secured a USPTO trademark for its name in October 2024 [Instagram, retrieved 2024]. In March 2025, Womb WatchAI launched the "Her Health, Her Future" Research Fund [EIN Presswire, 2025]. The company has gained recognition through participation in the NVIDIA Inception Program and Google for Startups [F6S].

Data Accuracy: YELLOW -- Key founding details are confirmed by the founder's public profile and company materials, but program participation details are from a single aggregator source.

The Product and the Stack

The company's core proposition is a proprietary AI system designed to interpret complex biological data for women's health. Womb WatchAI's platform is anchored by its Bio-Intent Orchestration System™ (BIOS™), a foundational intelligence layer the company claims can decode over 64,000 biological variables [WOMEN OF WEARABLES, retrieved 2024]. This system powers the flagship consumer-facing product, Rhythm by Womb WatchAI®, an AI-powered app and Digital Twin platform [Womb WatchAI, retrieved 2024]. The application allows users to track a wide array of health indicators, including menstrual cycle symptoms, PCOS indicators, endometriosis pain patterns, nutrition, mood, and lifestyle factors [rhythmbywombwatchai.com, retrieved 2026].

The platform's stated analytical scope extends from routine wellness to serious disease surveillance, including period, nutrition, lab, and menstrual flow analysis, with integration into Apple and Google Health ecosystems [Womb WatchAI, retrieved 2024]. A claimed function is cancer surveillance and population-pattern recognition across five unspecified cancers [Womb WatchAI, retrieved 2024]. A key technical differentiator cited is the training of six proprietary AI models exclusively on female data [Womb WatchAI, retrieved 2024].

Metric	Value
Global Digital Health Market (2023)	$200B
Femtech Sector (2023)	$60B
Endometriosis Prevalence	10%
PCOS Prevalence	20%

Data Accuracy: YELLOW -- Market sizing figures are from third-party analyst reports and medical journals. Direct TAM/SAM/SOM for Womb WatchAI's specific offering is not publicly available.

The Competitive Field

Womb WatchAI enters a fragmented women's health technology landscape, positioning its proprietary AI system as a foundational intelligence layer.

Company	Positioning	Stage / Funding	Notable Differentiator
Womb WatchAI	AI operating system for women's health	Pre-Seed / Undisclosed	Proprietary models trained exclusively on female data
MindMics	In-ear wearable	Seed / $3M	Non-invasive biometric monitoring
Crescent Health	Chronic condition management	Series A / $20M	Longitudinal care coordination
Chorus	Virtual clinical trials	Series B / $45M	Infrastructure for clinical studies
Owaves	Wellness planner	Bootstrapped / Undisclosed	Behavioral design approach

Data Accuracy: YELLOW -- Competitor funding stages sourced from Crunchbase; Womb WatchAI's differentiators are from its own materials.

Opportunity

The prize for building a foundational AI layer in women's health is the creation of a multi-billion dollar category leader. Womb WatchAI could become the default intelligence layer for women's health, akin to what Epic Systems is for hospital records but built on predictive, personalized AI. The company's core claim is a proprietary system, the Bio-Intent Orchestration System™ (BIOS™), designed to decode over 64,000 biological variables [WOMEN OF WEARABLES, retrieved 2024].

Data Accuracy: YELLOW -- Core technology and product claims are sourced from company materials; growth scenarios are plausible but hinge on unverified future catalysts.

Sources

1. [Womb WatchAI, retrieved 2024] https://www.wombwatchai.com/about-us
2. [WOMEN OF WEARABLES, retrieved 2024] https://www.womenofwearables.com/new-blog/wow-woman-in-biotech-quanda-francis-founder-and-chief-technology-officer-of-womb-watchai
3. [Instagram, retrieved 2024] https://www.instagram.com/wombwatchai/
4. [rhythmbywombwatchai.com, retrieved 2026] https://rhythmbywombwatchai.com
5. [LinkedIn, retrieved 2024] https://www.linkedin.com/in/quandafrancis
6. [EIN Presswire, 2025] https://www.einpresswire.com/article/...
7. [F6S] https://www.f6s.com/company/wombwatchai
8. [Grand View Research, 2024] https://www.grandviewresearch.com/industry-analysis/digital-health-market
9. [Frost & Sullivan, 2023] https://www.frost.com/frost-perspectives/the-future-of-femtech
10. [Journal of Endometriosis and Uterine Disorders, 2023] https://www.sciencedirect.com/science/article/pii/S2949891023000155
11. [The Lancet, 2023] https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(23)00817-9/fulltext
12. [Crunchbase] https://www.crunchbase.com/organization/mindmics
13. [Crunchbase] https://www.crunchbase.com/organization/crescent-health
14. [Crunchbase] https://www.crunchbase.com/organization/chorus-ai
15. [Crunchbase] https://www.crunchbase.com/organization/owaves
16. [Bloomberg, 2022] https://www.bloomberg.com/news/articles/2022-04-12/oura-valued-at-2-55-billion-in-funding-round-led-by-temasek-jazz-venture-partners